2013 will go down on record as one of the most significant years in the history of marijuana law reform. Here’s why.
The results of a first-of-its-kind worldwide survey of nearly 1,000 medicinal cannabis consumers shows that most patients prefer their medicine in the way that nature, not Big Pharma, intended it to be. Overall, subjects said that herbal cannabis preparations were more cost-effective and posed fewer side-effects than cannabis-derived pharmaceuticals.
Members of the Oregon House and Senate have given final approval to House Bill 3460, which licenses medicinal cannabis dispensaries statewide. House Bill 3460 “directs [the] Oregon Health Authority to establish a registration system for medical marijuana facilities.” The department has until March 2014 to draft rules regulating dispensaries. Such facilities exist presently in the state but are unregulated and remain subject to state and local prosecution. Officials expect to register an estimated 225 dispensaries in the first two years.
House and Senate negotiators on Tuesday agreed on a final version of House Bill 573, which allows for a regulated system of medical cannabis distribution in New Hampshire. The amended bill calls for the creation of four state-sanctioned marijuana dispensing facilities to produce and distribute cannabis to state-qualified patients who possess a physician’s recommendation. New Hampshire will become the 19th state to allow for the limited, legal use of medical cannabis and the final New England state to do so.
Another study has once again affirmed that the enactment of statewide medical cannabis laws is not associated with increased rates of adolescent marijuana consumption. According to data published this week in the American Journal of Public Health, the passage of medical marijuana laws in various states has had no “statistically significant … effect on the prevalence of either lifetime or 30-day marijuana use” by adolescents residing in those states.
Lawmakers gave final approval on Monday to legislation, Senate Bill 374, to allow for the establishment of licensed facilities to dispense cannabis to state-qualified patients. The measure passed with two-thirds majorities in both legislative chambers. It now awaits action from Republican Gov. Brian Sandoval, who has previously acknowledged that he is open to the idea of regulating medical cannabis dispensaries.
Students for Sensible Drug Policy and the Silver Tour will convene a medical marijuana training session and lobby day in Washington D.C. to encourage Congress and the Obama Administration to allow states greater autonomy to create their own cannabis policies without political pressure from the federal government. Lobby training session is scheduled for Sunday, June 16, with legislative lobbying all day Monday, June 17. For more information about the schedule, speakers and activities, please visit here. Joining SSDP is the senior citizen medical cannabis educational project The Silver Tour, which […]
Members of the New Hampshire Senate voted 18 to 6 today in favor of an amended version of House Bill 573, which allows for the physician-authorized use and state-licensed dispensing of cannabis to qualified patients. The Senate version of the bill now goes back to the House, whose members will either sign off on or, more likely, reject the Senate’s amendments. The latter action would create the need for a “committee of conference,” at which time a special committee of House representatives and senators will compromise on a final version of the bill. That language will then be forwarded to the governor’s desk.
A Michigan traffic safety law that prohibits the operation of a motor vehicle by persons who possess any presence of THC in their blood, regardless of whether or not they are behaviorally impaired by the substance, may not be strictly applied to state-qualified medical cannabis patients.
Inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients non-responsive to traditional therapies, according to clinical trial data published online ahead of print in the journal Clinical Gastroenterology and Hepatology. The study is the first placebo-controlled clinical trial to assess the consumption of cannabis for the treatment of Crohn’s.